BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Drug Development

  Array BioPharma, Inc. Presents Positive Preclinical Data on Its Glucokinase Activators in Type 2 Diabetes

  September 25, 2008

   · 

  1 min read
• Drug Development

  Sepracor, Inc. Release: New Data Show Efficacy and Safety of Eslicarbazepine Acetate in the Treatment of Epilepsy

  September 25, 2008

   · 

  1 min read
• Policy

  3SBio Inc. Files for SFDA Approval of High-dose (36,000 IU) EPIAO

  September 25, 2008

   · 

  3 min read
• Business

  Xpention Genetics, Inc. Successfully Completes Gene Synthesis and Expression

  September 25, 2008

   · 

  1 min read
• Drug Development

  CSL Behring Release: Data Published in Journal of Clinical Immunology Show Privigen(TM) Demonstrates Effectiveness and Tolerability in Patients with Primary Immunodeficiencies

  September 25, 2008

   · 

  1 min read
• BioMidwest

  SensiGen LLC HPV Assay Enables Major Breakthrough in Diagnosis and Treatment of Head and Neck Cancer

  September 25, 2008

   · 

  1 min read
• Business

  Schering-Plough Corporation Schedules Conference Call and Webcast for 2008 Third Quarter Earnings

  September 25, 2008

   · 

  1 min read
• Policy

  Ipsen Announces the Filing of Decapeptyl(R) 6-month Formulation for the Treatment of Locally Advanced or Metastatic Prostate Cancer in Europe

  September 25, 2008

   · 

  1 min read
• BioForest

  MDRNA, Inc. Receives NASDAQ Notice Letter

  September 25, 2008

   · 

  1 min read
• Business

  Cato T. Laurencin, M.D., Ph.D. to Join Osteotech, Inc. Board of Directors

  September 25, 2008

   · 

  1 min read